Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Plum

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry|October 13, 2009
Removal of the 20-methyl group from 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D(3) (2MD) selectively eliminates bone calcium mobilization activityRafal Barycki, Rafal R Sicinski, Lori A Plum, et al.
Bioorganic & Medicinal Chemistry|October 25, 2011
13,13-Dimethyl-des-C,D analogues of (20S)-1α,25-dihydroxy-2-methylene-19-norvitamin D₃ (2MD): total synthesis, docking to the VDR, and biological evaluationKatarzyna Plonska-Ocypa, Izabela Sibilska, Rafal R Sicinski, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2002
A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formationNirupama K Shevde, Lori A Plum, Margaret Clagett-Dame, et al.
Bioorganic Chemistry|November 19, 2021
Novel superagonist analogs of 2-methylene calcitriol: Design, molecular docking, synthesis and biological evaluationIzabela K Sibilska-Kaminski, Adrian Fabisiak, Pawel Brzeminski, et al.
American Journal of Nephrology|May 24, 2014
Novel, selective vitamin D analog suppresses parathyroid hormone in uremic animals and postmenopausal womenJulia B Zella, Lori A Plum, David R Plowchalk, et al.
Developmental Biology|March 10, 2001
Connexin31-deficiency in mice causes transient placental dysmorphogenesis but does not impair hearing and skin differentiationA Plum, E Winterhager, J Pesch, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2004
Biologically active noncalcemic analogs of 1alpha,25-dihydroxyvitamin D with an abbreviated side chain containing no hydroxylLori A Plum, Jean M Prahl, Xiaohong Ma, et al.
Bioorganic & Medicinal Chemistry|January 27, 2009
13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluationKatarzyna Plonska-Ocypa, Rafal R Sicinski, Lori A Plum, et al.
Journal of Medicinal Chemistry|April 12, 2012
A 20S combined with a 22R configuration markedly increases both in vivo and in vitro biological activity of 1α,25-dihydroxy-22-methyl-2-methylene-19-norvitamin D3Agnieszka Flores, Rafal R Sicinski, Pawel Grzywacz, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 2, 2005
Responsiveness of human retinoblastoma and neuroblastoma models to a non-calcemic 19-nor Vitamin D analogDaniel M Albert, Lori A Plum, William Yang, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry|October 13, 2009
Removal of the 20-methyl group from 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D(3) (2MD) selectively eliminates bone calcium mobilization activityRafal Barycki, Rafal R Sicinski, Lori A Plum, et al.
Bioorganic & Medicinal Chemistry|October 25, 2011
13,13-Dimethyl-des-C,D analogues of (20S)-1α,25-dihydroxy-2-methylene-19-norvitamin D₃ (2MD): total synthesis, docking to the VDR, and biological evaluationKatarzyna Plonska-Ocypa, Izabela Sibilska, Rafal R Sicinski, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2002
A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formationNirupama K Shevde, Lori A Plum, Margaret Clagett-Dame, et al.
Bioorganic Chemistry|November 19, 2021
Novel superagonist analogs of 2-methylene calcitriol: Design, molecular docking, synthesis and biological evaluationIzabela K Sibilska-Kaminski, Adrian Fabisiak, Pawel Brzeminski, et al.
American Journal of Nephrology|May 24, 2014
Novel, selective vitamin D analog suppresses parathyroid hormone in uremic animals and postmenopausal womenJulia B Zella, Lori A Plum, David R Plowchalk, et al.
Developmental Biology|March 10, 2001
Connexin31-deficiency in mice causes transient placental dysmorphogenesis but does not impair hearing and skin differentiationA Plum, E Winterhager, J Pesch, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2004
Biologically active noncalcemic analogs of 1alpha,25-dihydroxyvitamin D with an abbreviated side chain containing no hydroxylLori A Plum, Jean M Prahl, Xiaohong Ma, et al.
Bioorganic & Medicinal Chemistry|January 27, 2009
13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluationKatarzyna Plonska-Ocypa, Rafal R Sicinski, Lori A Plum, et al.
Journal of Medicinal Chemistry|April 12, 2012
A 20S combined with a 22R configuration markedly increases both in vivo and in vitro biological activity of 1α,25-dihydroxy-22-methyl-2-methylene-19-norvitamin D3Agnieszka Flores, Rafal R Sicinski, Pawel Grzywacz, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 2, 2005
Responsiveness of human retinoblastoma and neuroblastoma models to a non-calcemic 19-nor Vitamin D analogDaniel M Albert, Lori A Plum, William Yang, et al.
Pageof 10